High RAD51 protein expression in oral cancer tissues had a poor impact on the OS of OSCC patients receiving adjuvant chemotherapy and a significantly negative influence on the PFS of OSCC patients receiving adjuvant radiotherapy. This evidence concerns the gene RAD51 and lip and oral cavity carcinoma.